Autopsy report · NCT00493831

Analysis of Lipid Biomarkers of Exposure and Host Response

“primary analyses found futile”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 9 months after it had already started.
• Ran for about 2 years 1 month before it stopped.
• 24 participants enrolled.
• Results were posted on the registry 15 years 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Nebraska

Sponsor type

University, hospital or other

Conditions

Cigarette Smoking

Interventions

nicotine polacrilex, transdermal system or inhaler

Participants

24

Sites

1

Countries

United States

Trials that died the same way

• A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
  “At the time of the primary analysis, results did not meet the primary endpoint” (59% match in meaning)
• Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
  “Study did not meet its primary objective” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.